Latest news
State Street Corporation (NYSE: STT) discloses 5.3% ownership in Corvus Pharmaceuticals - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 13:17:03 GMTCorvus Pharmaceuticals Inc (CRVS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 10:25:56 GMTCorvus Pharmaceuticals Inc (CRVS) (Q2 2026) Earnings Call Highlights: Advancing Soquelitinib ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:09:15 GMTCorvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:01:00 GMTCorvus Eczema Trial Is Expected to Enroll About 200 Patients - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 20:01:00 GMTCorvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026 - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTCorvus Pharmaceuticals' Q2 Business Update Will Stream Live Aug. 6 - stocktitan.netstocktitan.net · Thu, 30 Jul 2026 07:00:00 GMTBlackRock (CRVS holder) reports 7.5% beneficial stake in Corvus Pharmaceuticals - stocktitan.netstocktitan.net · Mon, 27 Jul 2026 20:28:19 GMT